Fair Value of Financial Instruments (Details 3) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 28, 2011
|
Nov. 30, 2010
|
Feb. 28, 2010
|
Feb. 29, 2012
|
Feb. 28, 2011
|
Feb. 28, 2010
|
Feb. 28, 2011
Nonrecurring [Member]
|
Nov. 30, 2010
Nonrecurring [Member]
|
Feb. 29, 2012
Nonrecurring [Member]
|
Feb. 28, 2011
Nonrecurring [Member]
|
Feb. 28, 2010
Nonrecurring [Member]
|
Nov. 30, 2009
Nonrecurring [Member]
|
Feb. 29, 2012
Nonrecurring [Member]
Quoted Prices in Active Markets (Level 1) [Member]
|
Feb. 28, 2011
Nonrecurring [Member]
Quoted Prices in Active Markets (Level 1) [Member]
|
Feb. 28, 2010
Nonrecurring [Member]
Quoted Prices in Active Markets (Level 1) [Member]
|
Feb. 29, 2012
Nonrecurring [Member]
Significant Other Observable Inputs (Level 2) [Member]
|
Feb. 28, 2011
Nonrecurring [Member]
Significant Other Observable Inputs (Level 2) [Member]
|
Feb. 28, 2010
Nonrecurring [Member]
Significant Other Observable Inputs (Level 2) [Member]
|
Feb. 29, 2012
Nonrecurring [Member]
Significant Unobservable Inputs (Level 3) [Member]
|
Feb. 28, 2011
Nonrecurring [Member]
Significant Unobservable Inputs (Level 3) [Member]
|
Feb. 28, 2010
Nonrecurring [Member]
Significant Unobservable Inputs (Level 3) [Member]
|
|
Assets and liabilities measured at fair value on a nonrecurring basis | |||||||||||||||||||||
Long-lived assets held for sale | $ 4.1 | $ 4.1 | $ 21.9 | $ 0 | $ 0 | $ 0 | $ 0 | $ 4.1 | $ 21.9 | ||||||||||||
Trademarks | 136.9 | 96.0 | 136.9 | 162.7 | 0 | 0 | 0 | 0 | 0 | 0 | 96.0 | 136.9 | 162.7 | ||||||||
Investment in equity method investee | 4.2 | 0 | 0 | 4.2 | |||||||||||||||||
Total | 0 | 0 | 0 | 0 | 141.0 | 188.8 | |||||||||||||||
Loss on long-lived assets held for sale | 5.8 | 13.4 | 5.8 | 13.4 | |||||||||||||||||
Impairment of trademarks | 16.7 | 6.9 | 103.2 | 38.1 | 23.6 | 103.2 | 16.7 | 6.9 | 38.1 | 23.6 | 103.2 | ||||||||||
Impairment on investment in equity method investee | 25.4 | 25.4 | |||||||||||||||||||
Total asset impairment charges | $ 29.4 | $ 142.0 |